Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Change in Cash (2016 - 2025)

Historic Change in Cash for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$1.7 million.

  • Lemaitre Vascular's Change in Cash fell 3283.35% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 5230.51%. This contributed to the annual value of $1.3 million for FY2024, which is 7388.51% down from last year.
  • As of Q3 2025, Lemaitre Vascular's Change in Cash stood at -$1.7 million, which was down 3283.35% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Change in Cash registered a high of $6.2 million during Q4 2023, and its lowest value of -$4.3 million during Q2 2024.
  • For the 5-year period, Lemaitre Vascular's Change in Cash averaged around -$66842.1, with its median value being -$1.3 million (2024).
  • As far as peak fluctuations go, Lemaitre Vascular's Change in Cash tumbled by 28467.93% in 2021, and later surged by 36350.81% in 2022.
  • Over the past 5 years, Lemaitre Vascular's Change in Cash (Quarter) stood at -$3.5 million in 2021, then skyrocketed by 163.2% to $2.2 million in 2022, then surged by 179.96% to $6.2 million in 2023, then dropped by 25.88% to $4.6 million in 2024, then tumbled by 136.52% to -$1.7 million in 2025.
  • Its Change in Cash was -$1.7 million in Q3 2025, compared to $1.8 million in Q2 2025 and -$270000.0 in Q1 2025.